Cargando…
Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
Chronic prescription of antipsychotics seems to lose its therapeutic benefits in the prevention of recurring psychotic symptoms. In many instances, the occurrence of relapse from initial remission is followed by an increase in dose of the prescribed antipsychotic. The current understanding of why th...
Autores principales: | Yin, John, Barr, Alasdair M., Ramos-Miguel, Alfredo, Procyshyn, Ric M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327459/ https://www.ncbi.nlm.nih.gov/pubmed/27264948 http://dx.doi.org/10.2174/1570159X14666160606093602 |
Ejemplares similares
-
Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review
por: Lian, Lulu, et al.
Publicado: (2022) -
Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
por: Tadokoro, Shigenori, et al.
Publicado: (2012) -
Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis
por: Lee, Lik Hang N., et al.
Publicado: (2018) -
Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine
por: Takao, Nagara, et al.
Publicado: (2021) -
Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021)